What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many ...
Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...
Devices boosts financial stability with a $70M desktop sale. Read why I'm taking my bearish view off the table for now on ...
Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage ...
Viewers can become desensitised to legal adult pornography and seek out more extreme material, a charity said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results